|
According to Dr. Ira L. Goldknopf, Chief Scientific Officer and Head of the
Scientific Team at Power3, "By utilizing our very sensitive and reproducible
proteomic methods with definitive patient samples, we discovered a series of
proteins whose concentrations in the bone marrow aspirate samples, taken from
Chronic Myelogenous Leukemia (CML) patients before treatment, demonstrated a
consistent correlation with whether the patients subsequently responded to the
treatment with a particular drug. The identities of these proteins, which
apparently detect the presence of drug resistant cancer cells prior to
treatment, also indicate a potential to design drugs to kill both sensitive and
resistant cancer cells."
New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: [email protected] Subscribe: [EMAIL PROTECTED] Unsubscribe: [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED] CML Group Web Site http://groups.yahoo.com/group/CML YAHOO! GROUPS LINKS
|
